BPG is committed to discovery and dissemination of knowledge
Open-Access Journal
Editorial
Review
Future of liver disease in the era of direct acting antivirals for the treatment of hepatitis C 
Francesca Romana Ponziani, Francesca Mangiola, Cecilia Binda, Maria Assunta Zocco, Massimo Siciliano, Antonio Grieco, Gian Lodovico Rapaccini, Maurizio Pompili, Antonio Gasbarrini 
World J Hepatol 9(7):352-367. Published online Mar 8, 2017. doi: 10.4254/wjh.v9.i7.352
Basic Study
Characterization of a new monoclonal anti-glypican-3 antibody specific to the hepatocellular carcinoma cell line, HepG2 
Preeyanat Vongchan, Robert J Linhardt 
World J Hepatol 9(7):368-384. Published online Mar 8, 2017. doi: 10.4254/wjh.v9.i7.368
Case Control Study
Risk factors for hepatocellular carcinoma in cirrhosis due to nonalcoholic fatty liver disease: A multicenter, case-control study 
Kathleen E Corey, Samer Gawrieh, Andrew S deLemos, Hui Zheng, Andrew E Scanga, Jennifer W Haglund, Jorge Sanchez, Christopher J Danford, Megan Comerford, Krista Bossi, Samina Munir, Naga Chalasani, Julia Wattacheril 
World J Hepatol 9(7):385-390. Published online Mar 8, 2017. doi: 10.4254/wjh.v9.i7.385
Retrospective Study
Features of hepatocellular carcinoma in Hispanics differ from African Americans and non-Hispanic Whites 
Neeta K Venepalli, Mary V Modayil, Stephanie A Berg, Tad D Nair, Mayur Parepally, Priyanka Rajaram, Ron C Gaba, James T Bui, Yue Huang, Scott J Cotler 
World J Hepatol 9(7):391-400. Published online Mar 8, 2017. doi: 10.4254/wjh.v9.i7.391
Prospective Study
Phase angle obtained by bioelectrical impedance analysis independently predicts mortality in patients with cirrhosis 
Giliane Belarmino, Maria Cristina Gonzalez, Raquel S Torrinhas, Priscila Sala, Wellington Andraus, Luiz Augusto Carneiro D’Albuquerque, Rosa Maria R Pereira, Valéria F Caparbo, Graziela R Ravacci, Lucas Damiani, Steven B Heymsfield, Dan L Waitzberg 
World J Hepatol 9(7):401-408. Published online Mar 8, 2017. doi: 10.4254/wjh.v9.i7.401